Severe serum sickness-like syndrome after omalizumab therapy for asthma.
Pilette
Charles
C
Coppens
Nathalie
N
Houssiau
Frédéric A
FA
Rodenstein
Daniel O
DO
D000368:Aged; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069444:Omalizumab; D012713:Serum Sickness / Q000139:chemically induced*; D013577:Syndrome
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab